Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer

Emerging research with immune checkpoint inhibitors in basal cell carcinoma (BCC)

Date

22 Sep 2020

Session

Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer

Presenters

Susana Puig

Authors

S. Puig

Author affiliations

  • Melanoma Unit, Dermatology Department, Hospital Clinic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Barcelona/ES
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings